Elliot F. Hahn, Ph.D. currently serves as Vice Chairman and Executive Director of Izun Pharmaceuticals Corporation. Dr. Hahn is also the Executive Chairman of Accu-Break Pharmaceuticals, Inc., a privately held company. He co-founded Andrx Corporation and was Chairman Emeritus and a Director of Andrx until its acquisition by Watson Pharmaceuticals, Inc. in November 2006 for $1.9 billion. He was President of Andrx from 1993 until 2003, served as Chairman of the Board from 2002-03 and as interim CEO from 2001-02. From June 1990 until February 1993, Dr. Hahn was Vice President for Scientific Affairs of IVAX, where he was involved in the evaluation and licensing of product opportunities and was responsible for maintaining IVAX’s intellectual property. Prior to that, he was Vice President of Research at the pharmaceutical subsidiary of IVAX.